Dizal Pharma

Dizal Pharma logo2
Your Solutions
Pharmaprojects Login image
PHARMAPROJECTS

Global R&D Intelligence - Novel Drug
全球R&D综合数据 - 创新药
Product Login
Trialtrove Login image
TRIALTROVE

Global R&D Intelligence - Clinical Trial
全球R&D综合数据 - 临床试验
Product Login
Sitetrove Login image
SITETROVE

Global R&D Intelligence - Investigator/Site, Patient RWD
全球R&D综合数据 - 研究者/临床中心、患者RWD
Product Login
Person standing in front of a presentation screen.
BIOMEDTRACKER

Real-time Event Tracking & Drug Development Analysis
管线研发追踪、获批前景分析、商业资讯、调研报告
*Limited License
Product Login
Datamonitor Healthcare Login image
DATAMONITOR HEALTHCARE
Disease Competitive Analysis, 10-20 Years Market Forecast, KOL Insights
疾病竞争分析、10-20年市场预测、KOL专访
*Limited License
Product Login

Training & Help

We provide product training support via online sessions/pre-recorded materials, please click below to access relevant contents, or reach out to this email for any customized training request: [email protected]

我们提供各产品的使用培训支持,请点击下列查阅相关培训资源,若有特定培训需求或安排则可联系:[email protected]


For access or technical issues, please contact your dedicated support team via 'Meet the Team', or contact Client Service team via below email:

若有任何登录问题,请切换至Meet the Team版面并联系对接服务团队,或可联系全球/亚太客服团队:

Global - [email protected] (English only)

APAC - [email protected] (via English/Chinese)

Require Research Support?
Ask-the-Analyst™

Your status as a loyalty partner includes unlimited access to our highly acclaimed Ask-the-Analyst™ service. With a 24-hour response time, Ask-the-Analyst offers you authoritative information to help you make faster, smarter business decisions.

作为重点合作伙伴,贵司用户均可无限量使用Ask-the-Analyst™分析师咨询服务!分析师团队将会在24小时内回复(工作日)并为您提供信息收集或专业见解,最终助您做出更快、更明智的业务决策。

Our Ask-the-Analyst team of industry experts leverages the complete suite of pharma intelligence products and publicly available sources to bring you the answers you’re looking for, while your information and all questions received are strictly confidential.

由业界专家组成的分析师团队将结合内部数据与公开领域资源为您提供支持,您的个人资讯与提问内容均会被严格保密。

Business professional posing at an office.

 

Latest Monthly Newsletter

Edition: March 2025

 

NEWS & INSIGHTS (incl. Key Themes, Latest Interviews, Recent Reg. Guidance)

  • Notable Theme (Commercial): The Trump Administration’s various pronouncements on tariffs has been a key theme, although impact on pharma/biotech/medtech is not fixed or clear. Early in the month, biotech stocks rose while some pharma companies saw their share prices decline, particularly those with expansive global manufacturing footprints. J&J became the latest US big pharma to announce major investment in US manufacturing and infrastructure. MedTech Europe has called on the EU to seek to exclude medical technologies from tariffs, and beauty business leaders are also speaking out against tariffs on personal care and cosmetics items.
  • Notable Theme (Commercial): The wave of interest and investment in obesity therapy continues with Roche signing the biggest deal in the space to date, partnering with Zealand to a total potential deal value of $5.3bn, centered on the latter’s Phase IIb-stage candidate petrelintide. However, promising unpartnered assets in this space are now becoming scarcer.
  • Notable Theme (Regulatory): When HHS announced it would lay off 3,500 people at the FDA, it was reported that employees read to find out what was happening because of the limited official communication. The Pink Sheet had provided detailed information about the scope of the layoffs, who was impacted, and where the agency could suffer. Further concerns that the upcoming user fee negotiations, which impact more than $1bn in FDA funding, could slow down because of staffing concerns, a scoop that went beyond the news of the day that other outlets favored.

 

EDITORIAL CONTENTS (incl. Podcasts, Webinars)

  • Notable Podcast: Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA
  • Notable Webinar (Upcoming): Pharma R&D Review 2025 (Apr 15, 2025)
  • Notable Webinar (Upcoming): The First-to-Market Myth: What Really Drives Launch Success? (Apr 30, 2025)

 

DEALS & FINANCING (incl. M&As, Licensing, Financing)

  • Notable M&A: Mallinckrodt Enters into Merger Agreement with Endo for $6.7B
  • Notable Licensing: Zealand Pharma and Roche Enter Collaboration and License Agreement to Co-Develop and Co-Commercialize Petrelintide Totalling $5.25B ($1.65B upfront)
  • Notable Financing: Isomorphic Labs Raised $600M in Funding Round

 

KEY R&D EVENTS (incl. Top-line Readouts, Analyst Commentary, Approval/CRL)

  • Notable Analysis: Takeda | Rusfertide | Polycythemia Vera (Phase 3): “Positive Phase III results help clear the path for approval of rusferitide, a potentially first-in-class hepcidin mimic for polycythemia vera…”
  • Notable Analysis: Novo Nordisk | CagriSema | Obesity (Phase 3): “Novo Nordisk’s CagriSema’s weight loss in obese patients with T2D disappoints despite meeting primary endpoint…”
  • Notable Analysis: J&J | Icotrokinra | Psoriasis (Phase 3): “Icotrokinra, a promising oral peptide therapy for psoriasis, potentially surpassed some biologics and approved oral drugs…”

 

RESEARCH REPORTS (incl. Forecast, Thought Leadership, KOL Interview)

    • Notable Report: Pharma R&D Annual Review 2025
    • Notable Report: 2025 Orphan Drug Report: Are Orphans That Different?
    • Notable Report: Dealmaking Quarterly Statistics, Q4 2024 | Financing Quarterly Statistics, Q4 2024
    • Notable Report: Patient-based Forecast: Bladder Cancer
    • Notable Report: Patient-based Forecast: Myasthenia Gravis (MG)
    • Notable Report: Patient-based Forecast: Meningococcal Vaccines

 

''

 

Latest Editorial Podcasts

 

Conference Disclosures via Trialtrove

Last Updated: May 2025
 
Every year, Trialtrove analysts review thousands of abstracts from 160+ scientific meetings/conferences and update the corresponding trial records when the information is in scope. This includes, but not limited to: trial results, trial design, study status, patient accrual information. Below, we have provided search links that will take you directly to trials where information was added from a selection of major meetings that have taken place since 2021.
Note: Require research support on scientific meetings not under below list? Submit your inquiry via Ask the Analyst!
Trialtrove分析师团队每年审阅全球160+医学年会的数千篇摘要披露,并在经过数据审核后将相关信息收录于数据库,其中包括:临床数据披露、临床方案更新、项目状态、入组进度等信息。下列表格为2021年至今全球各大领域重要医学会议的检索链接,以便快速找到有在某会议中披露最新动态的临床试验。
注:若想查阅未在下列范围内的医学会议,欢迎使用Ask the Analyst服务寻求辅助。

 

 

Therapeutic Area Conference 2021 2022 2023 2024 2025
Autoimmune/
Inflammation
American Academy of Dermatology (AAD) LINK LINK LINK LINK LINK
Digestive Disease Week (DDW) LINK LINK LINK LINK
LINK
American Thoracic Society (ATS) LINK LINK LINK LINK  
European Congress of Rheumatology (EULAR) LINK LINK LINK LINK
 
American College of Rheumatology (ACR Convergence) LINK LINK LINK LINK  
Cardiovascular American College of Cardiology (ACC) LINK LINK LINK LINK
LINK
European Society of Hypertension & International Society of Hypertension (ESH-ISH) LINK LINK LINK LINK  
International Society on Thrombosis and Hemostasis (ISTH) LINK LINK LINK LINK
 
CNS American Academy of Neurology (AAN) LINK LINK LINK LINK LINK
European Academy of Neurology (EAN) LINK LINK LINK LINK
 
Alzheimer's Association International Conference (AAIC) LINK LINK LINK LINK
 
European Committee for Treatment & Research in Multiple Sclerosis (ECTRIMS) LINK LINK LINK LINK  
World Congress of Neurology (WCN) LINK - LINK -  
Infectious
Disease
Asian Pacific Association for the Study of the Liver (APASL) LINK LINK LINK LINK LINK
Conference on Retroviruses and Opportunistic Infections (CROI) LINK LINK LINK LINK LINK
European Association for the Study of Liver (EASL) LINK LINK LINK LINK  
American Association for the Study of Liver Diseases (AASLD) LINK LINK LINK LINK  
Metabolic/
Endocrinology
American Diabetes Association (ADA) LINK LINK LINK LINK  
European Association for the Study of Liver (EASL) LINK LINK LINK LINK  
European Association for the Study of Diabetes (EASD) LINK LINK LINK LINK  
American Association for the Study of Liver Diseases (AASLD) LINK LINK LINK LINK  
Oncology American Association of Cancer Research (AACR) LINK LINK LINK LINK LINK
American Society of Clinical Oncology (ASCO) LINK LINK LINK LINK  
European Society of Medical Oncology (ESMO) LINK LINK LINK LINK  
American Society of Hematology (ASH) LINK LINK LINK LINK
 
Ophthalmology Asia-Pacific Academy of Ophthalmology (APAO) LINK - LINK - LINK
Association for Research in Vision and Ophthalmology (ARVO) LINK LINK LINK LINK LINK
European Society of Ophthalmology (SOE) N/A - LINK -  
World Glaucoma Congress (WGC) LINK - LINK -  

 

Note: 
Blank field - future meeting/not yet covered
Dash (-) -  no meeting/biannual schedule
N/A - abstracts not publicly available